Opioids and HIV infection

From pain management to addiction treatment

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

HIV-infected persons are more likely to have chronic pain, receive opioid analgesic treatment, receive higher doses of opioids, and to have substance use disorders and mental illness compared with the general population, putting them at increased risk for opioid use disorder. Management of opioid use in HIV-infected individuals can be complex, and the limited data on opioid treatment in this population are conflicting with regard to its effect on HIV outcomes. Buprenorphine treatment for opioid use disorder improves HIV outcomes and other outcomes. This article summarizes a presentation by Chinazo O. Cunningham, MD, MS at the IAS–USA continuing education program, Improving the Management of HIV Disease, held in Atlanta, Georgia, in March 2017.

Original languageEnglish (US)
Pages (from-to)143-146
Number of pages4
JournalTopics in antiviral medicine
Volume25
Issue number4
StatePublished - Dec 1 2017

Fingerprint

Pain Management
Opioid Analgesics
HIV Infections
HIV
Therapeutics
Buprenorphine
Continuing Education
Disease Management
Chronic Pain
Population
Substance-Related Disorders

Keywords

  • Buprenorphine
  • Chronic pain
  • HIV
  • Opioid analgesia
  • Opioid use disorder
  • Opioids

ASJC Scopus subject areas

  • Pharmacology
  • Infectious Diseases
  • Pharmacology (medical)
  • Virology

Cite this

Opioids and HIV infection : From pain management to addiction treatment. / Cunningham, Chinazo O.

In: Topics in antiviral medicine, Vol. 25, No. 4, 01.12.2017, p. 143-146.

Research output: Contribution to journalArticle

@article{97245398df144078be266ef8af43001a,
title = "Opioids and HIV infection: From pain management to addiction treatment",
abstract = "HIV-infected persons are more likely to have chronic pain, receive opioid analgesic treatment, receive higher doses of opioids, and to have substance use disorders and mental illness compared with the general population, putting them at increased risk for opioid use disorder. Management of opioid use in HIV-infected individuals can be complex, and the limited data on opioid treatment in this population are conflicting with regard to its effect on HIV outcomes. Buprenorphine treatment for opioid use disorder improves HIV outcomes and other outcomes. This article summarizes a presentation by Chinazo O. Cunningham, MD, MS at the IAS–USA continuing education program, Improving the Management of HIV Disease, held in Atlanta, Georgia, in March 2017.",
keywords = "Buprenorphine, Chronic pain, HIV, Opioid analgesia, Opioid use disorder, Opioids",
author = "Cunningham, {Chinazo O.}",
year = "2017",
month = "12",
day = "1",
language = "English (US)",
volume = "25",
pages = "143--146",
journal = "Topics in antiviral medicine",
issn = "2161-5853",
publisher = "International Antiviral Society",
number = "4",

}

TY - JOUR

T1 - Opioids and HIV infection

T2 - From pain management to addiction treatment

AU - Cunningham, Chinazo O.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - HIV-infected persons are more likely to have chronic pain, receive opioid analgesic treatment, receive higher doses of opioids, and to have substance use disorders and mental illness compared with the general population, putting them at increased risk for opioid use disorder. Management of opioid use in HIV-infected individuals can be complex, and the limited data on opioid treatment in this population are conflicting with regard to its effect on HIV outcomes. Buprenorphine treatment for opioid use disorder improves HIV outcomes and other outcomes. This article summarizes a presentation by Chinazo O. Cunningham, MD, MS at the IAS–USA continuing education program, Improving the Management of HIV Disease, held in Atlanta, Georgia, in March 2017.

AB - HIV-infected persons are more likely to have chronic pain, receive opioid analgesic treatment, receive higher doses of opioids, and to have substance use disorders and mental illness compared with the general population, putting them at increased risk for opioid use disorder. Management of opioid use in HIV-infected individuals can be complex, and the limited data on opioid treatment in this population are conflicting with regard to its effect on HIV outcomes. Buprenorphine treatment for opioid use disorder improves HIV outcomes and other outcomes. This article summarizes a presentation by Chinazo O. Cunningham, MD, MS at the IAS–USA continuing education program, Improving the Management of HIV Disease, held in Atlanta, Georgia, in March 2017.

KW - Buprenorphine

KW - Chronic pain

KW - HIV

KW - Opioid analgesia

KW - Opioid use disorder

KW - Opioids

UR - http://www.scopus.com/inward/record.url?scp=85044295649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044295649&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 143

EP - 146

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5853

IS - 4

ER -